Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2012 (2012), Article ID 312564, 6 pages
http://dx.doi.org/10.1155/2012/312564
Clinical Study

A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi

1Department of Internal Medical Services, Ballarat Health Services, Ballarat, VIC 3350, Australia
2Tiyanjane Clinic, Queen Elizabeth Central Hospital, C/- University of Malawi College of Medicine, Private Bag 360, Chichiri, Blantyre 3, Malawi
3University of Malawi, College of Medicine, Private Bag 360, Chichiri, Blantyre 3, Malawi

Received 14 September 2011; Revised 30 November 2011; Accepted 28 December 2011

Academic Editor: Ann Duerr

Copyright © 2012 H. Francis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. T. Banda, D. M. Parkin, C. P. Dzamalala, and N. G. Liomba, “Cancer incidence in Blantyre, Malawi 1994–1998,” Tropical Medicine and International Health, vol. 6, no. 4, pp. 296–304, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. A. E. Grulich, Y. Li, A. M. McDonald, P. K. Correll, M. G. Law, and J. M. Kaldor, “Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy,” AIDS, vol. 15, no. 5, pp. 629–633, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. Engels, R. M. Pfeiffer, J. J. Goedert et al., “Trends in cancer risk among people with AIDS in the United States 1980–2002,” AIDS, vol. 20, no. 12, pp. 1645–1654, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Makombe, A. D. Harries, J. K. L. Yu et al., “Outcomes of patients with Kaposi's sarcomawho start antiretroviral therapy under routine programme conditions in Malawi,” Tropical Doctor, vol. 38, no. 1, pp. 5–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. O. Malawi, Malawi HIV and AIDS Monitoring and Evaluation Report: 2008-2009, Lilongwe, Malawi, 2008.
  6. World Health Orginization, Progress on Global Access to HIV Antiretroviral Therapy. A Report ′3 by ′5 and Beyond, Geneva, Switzerland, 2006.
  7. G. O. Malawi, Malawi Ministry of Health: Management of HIV-Related Diseases, Lilongwe, Malawi, 2004.
  8. R. Harding, K. Stewart, K. Marconi, J. F. O'Neill, and I. J. Higginson, “Current HIV/AIDS end-of-life care in sub-Saharan Africa: a survey of models, services, challenges and priorities,” BMC Public Health, vol. 3, article 33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Harding and I. J. Higginson, “Palliative care in sub-Saharan Africa,” The Lancet, vol. 365, no. 9475, pp. 1971–1977, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Powell, J. Downing, R. Harding, F. Mwangi-Powell, and S. Connor, “Development of the APCA African palliative outcome scale,” Journal of Pain and Symptom Management, vol. 33, no. 2, pp. 229–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. “Interim proposal for a WHO staging system for HIV infection and disease,” Weekly Epidemiological Record. Releve Epidemiologique Hebdomadaire, vol. 65, no. 29, pp. 221–224, 1990.
  12. S. E. Krown, C. Metroka, and J. C. Wernz, “Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS clinical trials group oncology committee,” Journal of Clinical Oncology, vol. 7, no. 9, pp. 1201–1207, 1989. View at Google Scholar
  13. D. A. Karnofsky and J. H. Borchenal, Eds., The Clinical Evaluation of Chemotherapeutic Agents in Cancer, Columbia University Press, New York, NY, USA, 1949.
  14. D. W. Northfelt, B. J. Dezube, J. A. Thommes et al., “Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial,” Journal of Clinical Oncology, vol. 16, no. 7, pp. 2445–2451, 1998. View at Google Scholar · View at Scopus
  15. S. Stewart, H. Jablonowski, F. D. Goebel et al., “Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International pegylated liposomal doxorubicin study group,” Journal of Clinical Oncology, vol. 16, no. 2, pp. 683–691, 1998. View at Google Scholar
  16. S. E. Krown, “Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma,” Journal of Clinical Oncology, vol. 22, no. 3, pp. 399–402, 2004. View at Google Scholar · View at Scopus
  17. C. L. Olweny, M. Borok, I. Gudza et al., “Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial,” International Journal of Cancer, vol. 113, no. 4, pp. 632–639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Bihl, A. Mosam, L. N. Henry et al., “Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma,” AIDS, vol. 21, no. 10, pp. 1245–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. T. So, D. M. Holtzman, D. I. Abrams, and R. K. Olney, “Peripheral neuropathy associated with acquired immunodeficiency syndrome: prevalence and clinical features from a population-based survey,” Archives of Neurology, vol. 45, no. 9, pp. 945–948, 1988. View at Google Scholar · View at Scopus
  20. G. Schifitto, M. P. McDermott, J. C. McArthur et al., “Incidence of and risk factors for HIV-associated distal sensory polyneuropathy,” Neurology, vol. 58, no. 12, pp. 1764–1768, 2002. View at Google Scholar · View at Scopus
  21. C. L. Cherry, R. L. Skolasky, L. Lal et al., “Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort,” Neurology, vol. 66, no. 6, pp. 867–873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Maschke, O. Kastrup, S. Esser, B. Ross, U. Hengge, and A. Hufnagel, “Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART),” Journal of Neurology Neurosurgery and Psychiatry, vol. 69, no. 3, pp. 376–380, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Simpson, D. Kitch, S. R. Evans et al., “HIV neuropathy natural history cohort study: assessment measures and risk factors,” Neurology, vol. 66, no. 11, pp. 1679–1687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Shurie and A. Deribew, “Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals,” Ethiopian Medical Journal, vol. 48, no. 2, pp. 85–93, 2010. View at Google Scholar · View at Scopus
  25. M. Bower, M. Nelson, A. M. Young et al., “Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma,” Journal of Clinical Oncology, vol. 23, no. 22, pp. 5224–5228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Lodi, M. Guiguet, D. Costagliola, M. Fisher, A. de Luca, and K. Porter, “Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion,” Journal of the National Cancer Institute, vol. 102, no. 11, pp. 784–792, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Weigel, M. Hochgesang, M. W. Brinkhof et al., “Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi,” BMC Infectious Diseases, vol. 11, p. 31, 2011. View at Publisher · View at Google Scholar